These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34891386)

  • 1. Thammasat-NECTEC-Chula's Thai Language and Cognition Assessment (TLCA): The Thai Alzheimer's and Mild Cognitive Impairment Screening Test.
    Munthuli A; Vongsurakrai S; Anansiripinyo T; Ellermann V; Sroykhumpa K; Onsuwan C; Chutichetpong P; Hemrungrojn S; Kosawat K; Tantibundhit C
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():690-694. PubMed ID: 34891386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the Montreal Cognitive Assessment Thai Version to Discriminate Amnestic Mild Cognitive Impairment from Alzheimer's Disease and Healthy Controls: Machine Learning Results.
    Hemrungrojn S; Tangwongchai S; Charoenboon T; Panasawat M; Supasitthumrong T; Chaipresertsud P; Maleevach P; Likitjaroen Y; Phanthumchinda K; Maes M
    Dement Geriatr Cogn Disord; 2021; 50(2):183-194. PubMed ID: 34325427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Thai Picture Description Task for Alzheimer's Screening using Part-of-Speech Tagging.
    Sangchocanonta S; Vongsurakrai S; Sroykhumpa K; Ellermann V; Munthuli A; Anansiripinyo T; Onsuwan C; Hemrungrojn S; Kosawat K; Tantibundhit C
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():2104-2109. PubMed ID: 34891704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a modified Chinese version of Mini-Addenbrooke's Cognitive Examination for detecting mild cognitive impairment.
    Pan FF; Cui L; Li QJ; Guo QH
    Brain Behav; 2022 Jan; 12(1):e2418. PubMed ID: 34843170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between handgrip strength and cognition in a Chinese population with Alzheimer's disease and mild cognitive impairment.
    Su H; Sun X; Li F; Guo Q
    BMC Geriatr; 2021 Aug; 21(1):459. PubMed ID: 34380435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
    J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regression analysis of cerebral blood perfusion and cognitive function in patients with mild cognitive impairment and Alzheimer's disease].
    Xu Y; Chen LL; Su Y; Sun SN; Zhang HY
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):193-197. PubMed ID: 30669762
    [No Abstract]   [Full Text] [Related]  

  • 8. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
    Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
    Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The items in the Chinese version of the Montreal cognitive assessment basic discriminate among different severities of Alzheimer's disease.
    Zhang YR; Ding YL; Chen KL; Liu Y; Wei C; Zhai TT; Wang WJ; Dong WL
    BMC Neurol; 2019 Nov; 19(1):269. PubMed ID: 31684893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of the Thai version of the Mini-Addenbrooke's Cognitive Examination as a mild cognitive impairment and dementia screening test.
    Charernboon T
    Psychogeriatrics; 2019 Jul; 19(4):340-344. PubMed ID: 30699469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study on the validations of three cognitive screening tests in identifying subtle cognitive decline.
    Pan FF; Huang L; Chen KL; Zhao QH; Guo QH
    BMC Neurol; 2020 Mar; 20(1):78. PubMed ID: 32138678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjusting the Thai version of the Addenbrooke's Cognitive Examination III for education to screen for dementia.
    Charernboon T
    Neurodegener Dis Manag; 2021 Aug; 11(4):299-305. PubMed ID: 34232071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
    Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
    Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Thai Version of the Addenbrooke's Cognitive Examination III.
    Charernboon T; Jaisin K; Lerthattasilp T
    Psychiatry Investig; 2016 Sep; 13(5):571-573. PubMed ID: 27757137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of cognitive decline in mild cognitive impairment and Alzheimer's disease with a novel eye tracking test.
    Tadokoro K; Yamashita T; Fukui Y; Nomura E; Ohta Y; Ueno S; Nishina S; Tsunoda K; Wakutani Y; Takao Y; Miyoshi T; Higashi Y; Osakada Y; Sasaki R; Matsumoto N; Kawahara Y; Omote Y; Takemoto M; Hishikawa N; Morihara R; Abe K
    J Neurol Sci; 2021 Aug; 427():117529. PubMed ID: 34130064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care.
    Cui L; Zhang Z; Huang L; Li Q; Guo YH; Guo QH
    BMC Psychiatry; 2023 May; 23(1):368. PubMed ID: 37231438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.